Dogwood Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Dogwood Wealth Management's BMY Position: Q2 2026 in Review
Dogwood Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, selling an estimated $5.57K and leaving 597 shares worth $34.4K. The position accounts for 0.01% of the portfolio, ranked #189.
Dogwood Wealth Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $42.1K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Dogwood Wealth Management held 597 shares of Bristol-Myers Squibb worth $34.4K as of Q2 2026.
- Dogwood Wealth Management sold 97 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.57K.
- Bristol-Myers Squibb made up 0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #189 holding.
- Dogwood Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Dogwood Wealth Management's Bristol-Myers Squibb position peaked at $42.1K in Q1 2026.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.